{
    "2019-04-17": [
        [
            {
                "time": "2019-04-17",
                "original_text": "Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted",
                "features": {
                    "keywords": [
                        "Highly Rated",
                        "Biotech",
                        "54% Gain",
                        "Gutted"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "Health Care Sector Update for 04/17/2019: IONS,NVS,MASI,TXMD,ONCS",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "IONS",
                        "NVS",
                        "MASI",
                        "TXMD",
                        "ONCS"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "Here's Why Ionis Pharmaceuticals Slumped Today",
                "features": {
                    "keywords": [
                        "Ionis Pharmaceuticals",
                        "Slumped",
                        "Today"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "Marijuana ETF Down 9% in Past Month: Time to Enter the Space?",
                "features": {
                    "keywords": [
                        "Marijuana ETF",
                        "Down 9%",
                        "Past Month"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "marijuana"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO",
                "features": {
                    "keywords": [
                        "Daily Biotech Pulse",
                        "Zolgensma Data",
                        "Roche Q1 Results",
                        "Brainsway IPO"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales",
                "features": {
                    "keywords": [
                        "Radius Health",
                        "Rallies",
                        "33.4% YTD",
                        "Tymlos Sales"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-17",
                "original_text": "Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Phase III",
                        "ILLUMINATE-B",
                        "Lumasiran"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}